Analyse van vaccin efficiëntie voor malaria en tuberculose in co-infectie settings relevant voor endemische regio's in sub-Sahara AfrikaAssessment of vaccine efficacy for Malaria and Tuberculosis in a co-infection setting relevant for disease endemic sub-
Implications of the population structure of the Mycobacterium tuberculosis complex in Benin for tuberculosis presentation, diagnosis and outcome
Consequences of Mycobacterium tuberculosis genetic diversity in the context of HIV co-infection for laboratory diagnosis of tuberculosis in Africa
Usefulness of **Mycobacterium tuberculosis** molecular typing in a tuberculosis low-endemic agro-industrial setting of Brazil
GeneXpert MTB/RIF assay for the diagnosis of tuberculous lymphadenitis on concentrated fine needle aspirates in high tuberculosis burden settings
The predominance of Ethiopian specific Mycobacterium tuberculosis families and minimal contribution of Mycobacterium bovis in tuberculous lymphadenitis patients in Southwest Ethiopia
Potential contribution of HIV during first-line tuberculosis treatment to subsequent rifampicin-monoresistant tuberculosis and acquired tuberculosis drug resistance in South Africa
NEW DISUBSTITUTED TRIAZINE DIMER COMPOUNDS USEFUL FOR PREVENTING AND/OR TREATING E.G. PARASITIC DISEASE, VIRAL DISEASE, AFRICAN TRYPANOSOMIASIS, LEISHMANIASIS, MALARIA, HIV, TUBERCULOSIS, CHOLERA, DENGUE, DIARRHEA AND MEASLES
A Bayesian approach to estimate the probability of resistance to bedaquiline in the presence of a genomic variant